On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Blueprint Medicines (United States)

InstitutionResearch output, impact & collaborations

Blueprint Medicines (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Blueprint Medicines (United States)?

ScholarIQrecord summary

Blueprint Medicines (United States) is a research organisation in Cambridge, US. OpenAlex records 826 works and 90,668 citations for it. 412 researchers list it as their most recent affiliation.

How many works does Blueprint Medicines (United States) have?

ScholarIQindexed works

Blueprint Medicines (United States) has 826 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Blueprint Medicines (United States) →

How many citations does Blueprint Medicines (United States) have?

ScholarIQcitation count

Blueprint Medicines (United States) has 90,668 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Blueprint Medicines (United States) →

How many researchers are at Blueprint Medicines (United States)?

ScholarIQresearcher count

Blueprint Medicines (United States) has 412 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Blueprint Medicines (United States)?

ScholarIQavg h-index

Blueprint Medicines (United States) has an average h-index of 76.7 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Blueprint Medicines (United States)?

ScholarIQror

The ROR for Blueprint Medicines (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Blueprint Medicines (United States)?

ScholarIQopenalex

The OpenAlex for Blueprint Medicines (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Blueprint Medicines (United States)?

ScholarIQtop researchers by citations

Mark R. Rosenzweig · Gender, Labor, and Family Dynamics

751 works53,276 citations

Christoph Lengauer · Cancer Genomics and Diagnostics

215 works45,182 citations

Rachel Erlich · Cancer Genomics and Diagnostics

110 works21,264 citations

What are the most-cited papers on Blueprint Medicines (United States)?

ScholarIQmost cited works

Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Juliann Chmielecki, Xinyuan Lu, Todd M. Bauer, Mikhail Akimov, José A. Bufill, Carrie B. Lee, David Jentz, Rick Hoover, Sai‐Hong Ignatius Ou, Ravi Salgia, Timothy J. Brennan, Zachary R. Chalmers, Savina Jaeger, Alan Huang, Julia A. Elvin, Rachel Erlich, Alex Fichtenholtz, Kyle Gowen, Joel Greenbowe, Adrienne Johnson, Depinder Khaira, Caitlin McMahon, Eric M. Sanford, Steven Roels, Jared White, Joel Greshock, Robert Schlegel, Doron Lipson, Roman Yelensky, Deborah Morosini, Jeffrey S. Ross, Eric A. Collisson, Malte Peters, Philip J. Stephens, Vincent A. Miller

Cancer Discovery. 2015804 CitationsOPEN ACCESS

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

Anne Marie Lennon, Adam H. Buchanan, Isaac Kinde, Andrew Warren, Ashley Honushefsky, Ariella Cohain, David H. Ledbetter, Fred Sanfilippo, Kathleen Sheridan, Dillenia Rosica, Christian S. Adonizio, Hee Jung Hwang, Kamel Lahouel, Joshua D. Cohen, Christopher Douville, Aalpen A. Patel, Leonardo N. Hagmann, David D.K. Rolston, Nirav Malani, Shibin Zhou, Chetan Bettegowda, David L. Diehl, Bobbi Urban, Christopher D. Still, Lisa Kann, Julie Woods, Zachary Salvati, Joseph Vadakara, Rosemary Leeming, Prianka Bhattacharya, Carroll N. Walter, Alex Parker, Christoph Lengauer, Alison P. Klein, Cristian Tomasetti, Elliot K. Fishman, Ralph H. Hruban, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos

Science. 2020675 CitationsOPEN ACCESS

Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations

Alexa B. Schrock, Garrett M. Frampton, James Suh, Zachary R. Chalmers, Mark R. Rosenzweig, Rachel Erlich, Balázs Halmos, Jonathan W. Goldman, Patrick M. Forde, Kurt Leuenberger, Nir Peled, Gregory P. Kalemkerian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Sai‐Hong Ignatius Ou

Journal of Thoracic Oncology. 2016384 CitationsOPEN ACCESS

How much of the research on Blueprint Medicines (United States) is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

33%

Hybrid

33%

Bronze

33%

Closed